Total Payments
$3,916
2024 Payments
$544.34
Companies
19
Transactions
59
Medicare Patients
577
Medicare Billing
$75,234
Payment Breakdown by Category
Food & Beverage$3,916 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,916 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,071 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $619.46 | 20 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $376.81 | 3 | $0 (2022) |
| Becton, Dickinson and Company | $248.09 | 3 | $0 (2024) |
| Napo Pharmaceuticals Inc | $248.04 | 1 | $0 (2022) |
| Romark Laboratories, LC | $230.20 | 2 | $0 (2019) |
| Davol Inc. | $206.91 | 1 | $0 (2023) |
| QOL Medical, LLC | $174.99 | 1 | $0 (2021) |
| RedHill Biopharma Inc. | $150.00 | 1 | $0 (2021) |
| Celgene Corporation | $131.30 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $544.34 | 7 | Becton, Dickinson and Company ($207.95) |
| 2023 | $365.45 | 3 | Davol Inc. ($206.91) |
| 2022 | $518.46 | 5 | Napo Pharmaceuticals Inc ($248.04) |
| 2021 | $1,071 | 10 | AbbVie Inc. ($405.35) |
| 2020 | $139.67 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($118.38) |
| 2019 | $713.09 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($331.69) |
| 2018 | $372.30 | 8 | AbbVie, Inc. ($262.40) |
| 2017 | $191.16 | 4 | AbbVie, Inc. ($141.77) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $143.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | TELA Bio, Inc. | OviTex 2S (Device) | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: Surgical Mesh | ||||||
| 05/23/2024 | Laborie Medical Technologies Corp. | Solar Uroflow system (Device) | Food and Beverage | Cash or cash equivalent | $32.65 | General |
| Category: Gastroenterology | ||||||
| 05/23/2024 | Laborie Medical Technologies Corp. | Solar Uroflow system (Device) | Food and Beverage | Cash or cash equivalent | $4.90 | General |
| Category: Gastroenterology | ||||||
| 04/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/04/2024 | Becton, Dickinson and Company | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $138.50 | General |
| Category: Surgery | ||||||
| 02/27/2024 | Becton, Dickinson and Company | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $69.45 | General |
| Category: Surgery | ||||||
| 11/17/2023 | Becton, Dickinson and Company | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $40.14 | General |
| Category: Surgery | ||||||
| 08/15/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $118.40 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2023 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $206.91 | General |
| Category: Surgery | ||||||
| 11/03/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $121.44 | General |
| Category: Neuroscience | ||||||
| 10/25/2022 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | In-kind items and services | $248.04 | General |
| Category: Infectious Disease | ||||||
| 05/17/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Gastroenterology | ||||||
| 02/23/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Gastroenterology | ||||||
| 02/23/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.18 | General |
| Category: Gastroenterology | ||||||
| 12/07/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $136.64 | General |
| Category: Neuroscience | ||||||
| 12/06/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $116.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $118.73 | General |
| Category: Neuroscience | ||||||
| 09/21/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $145.00 | General |
| 07/22/2021 | Trevena, Inc. | Olinvyk (Drug) | Food and Beverage | Cash or cash equivalent | $15.59 | General |
| Category: Pain Management | ||||||
| 07/20/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Antibiotic | ||||||
| 06/14/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $143.83 | General |
| 05/25/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | In-kind items and services | $174.99 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/16/2021 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $49.66 | General |
| 03/24/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 140 | 204 | $37,690 | $19,652 |
| 2022 | 3 | 141 | 194 | $30,362 | $16,311 |
| 2021 | 3 | 134 | 187 | $32,306 | $18,824 |
| 2020 | 4 | 162 | 213 | $46,452 | $20,447 |
Total Patients
577
Total Services
798
Medicare Billing
$75,234
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 67 | 80 | $13,820 | $7,607 | 55.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 105 | $14,731 | $7,370 | 50.0% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 15 | 19 | $9,139 | $4,675 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 111 | $15,469 | $7,820 | 50.6% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 66 | 72 | $12,880 | $7,452 | 57.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,013 | $1,038 | 51.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 106 | $13,492 | $7,861 | 58.3% |
| 46600 | Diagnostic examination of the anus using an endoscope | Office | 2021 | 61 | 67 | $12,080 | $6,936 | 57.4% |
| 46922 | Removal of tissue abnormalities of anus | Office | 2021 | 12 | 14 | $6,734 | $4,027 | 59.8% |
| 46600 | Diagnostic examination of the anus using an endoscope | Office | 2020 | 69 | 80 | $15,860 | $6,842 | 43.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 103 | $15,166 | $5,910 | 39.0% |
| 46221 | Removal of hemorrhoid by rubber banding | Office | 2020 | 12 | 16 | $9,434 | $3,937 | 41.7% |
| 46500 | Injection of hemorrhoids | Office | 2020 | 12 | 14 | $5,992 | $3,759 | 62.7% |
About Dr. Brian Harlin, MD
Dr. Brian Harlin, MD is a Colon & Rectal Surgery healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609969500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Harlin, MD has received a total of $3,916 in payments from pharmaceutical and medical device companies, with $544.34 received in 2024. These payments were reported across 59 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,916).
As a Medicare-enrolled provider, Harlin has provided services to 577 Medicare beneficiaries, totaling 798 services with total Medicare billing of $75,234. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Colon & Rectal Surgery
- Location New York, NY
- Active Since 10/02/2006
- Last Updated 07/08/2007
- Taxonomy Code 208C00000X
- Entity Type Individual
- NPI Number 1609969500
Products in Payments
- Phasix Mesh (Device) $455.00
- ZEPOSIA (Drug) $376.81
- SKYRIZI (Biological) $261.81
- TRULANCE (Drug) $250.00
- Mytesi (Drug) $248.04
- XIFAXAN (Drug) $244.46
- Alinia (Drug) $230.20
- SUCRAID (Drug) $174.99
- Talicia (Drug) $150.00
- Humira (Biological) $141.77
- Ozanimod (Drug) $131.30
- PLENVU (Drug) $125.00
- VOQUEZNA (Drug) $125.00
- GATTEX (Drug) $117.14
- HUMIRA (Biological) $116.52
- Trulance (Drug) $48.42
- Solar Uroflow system (Device) $37.55
- OviTex 2S (Device) $30.43
- Axonics r-SNM System (Device) $21.29
- Olinvyk (Drug) $15.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Colon & Rectal Surgery Doctors in New York
Richard Whelan, M.d, M.D
Colon & Rectal Surgery — Payments: $46,454
Colon & Rectal Surgery $46,454
Dr. Mehraneh Jafari, Md, MD
Colon & Rectal Surgery — Payments: $40,639
Colon & Rectal Surgery $40,639
Dr. Parul Shukla, M.d, M.D
Colon & Rectal Surgery — Payments: $28,695
Colon & Rectal Surgery $28,695
Dr. David Schwartzberg, M.d, M.D
Colon & Rectal Surgery — Payments: $25,515
Colon & Rectal Surgery $25,515
Dr. Juliet Ray, M.d, M.D
Colon & Rectal Surgery — Payments: $16,290
Colon & Rectal Surgery $16,290
Dr. Debbie Bakes, M.d, M.D
Colon & Rectal Surgery — Payments: $15,834
Colon & Rectal Surgery $15,834